TCIM
MBIO icon

TIAA CREF Investment Management’s Mustang Bio MBIO Stock Holding History

TIAA CREF Investment Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$124K Buy
49
+23
+88% +$65.1K ﹤0.01% 2943
2018
Q4 		$58K Hold
26
– – ﹤0.01% 2992
2018
Q3 		$117K Sell
26
-8
-24% -$40K ﹤0.01% 3026
2018
Q2 		$176K Buy
+34
New +$215K ﹤0.01% 3046

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

TIAA CREF Investment Management's MBIO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Mustang Bio (MBIO) stake by 88% in Q1 2019, buying an estimated $65.1K and bringing the position to 49 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

TIAA CREF Investment Management first reported a position in MBIO in Q2 2018 and has held it in 4 quarters since. The position peaked at $176K in Q2 2018. 37 funds tracked by Wall St. Rank hold MBIO as of Q1 2019.

  • TIAA CREF Investment Management held 49 shares of Mustang Bio worth $124K as of Q1 2019.
  • TIAA CREF Investment Management bought 23 Mustang Bio shares in Q1 2019, an estimated $65.1K.
  • Mustang Bio made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2943 holding.
  • TIAA CREF Investment Management first reported a position in Mustang Bio in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Mustang Bio position peaked at $176K in Q2 2018.
  • 37 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.